Home Newsletters Cell Therapy News BlueCube Bio Becomes Evia Bio™ and Launches New IPSC Cryopreservation Solution to...

BlueCube Bio Becomes Evia Bio™ and Launches New IPSC Cryopreservation Solution to Accelerate Cell & Gene Therapies

0
BlueCube Bio officially announced a company name transition to Evia Bio™, concurrent with the launch of a significant new cryopreservation technology for use in cell and gene therapies utilizing iPSCs.
[BlueCube Bio (BioSpace, Inc.)]

Sorry, but the selected Zotpress account can't be found.

Press Release
Exit mobile version